Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Cyclopharm Limited (CYC) vs. Competitors

19 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:CYCCyclopharm LimitedAUD 0.46AUD 59.72M-2.97-30.83%Moderate BuyUnlock the AU:CYC analyst price target with TipRanks PremiumAU:CYCUnlock the AU:CYC top-analyst price target with TipRanks Premium
AU:CMPCompumedics LimitedAUD 0.24AUD 47.94M218.18-27.27%―Unlock the AU:CMP analyst price target with TipRanks PremiumAU:CYC vs AU:CMPUnlock the AU:CMP top-analyst price target with TipRanks Premium
AU:MX1Micro-X Ltd.AUD 0.03AUD 21.08M-1.96-67.78%HoldUnlock the AU:MX1 analyst price target with TipRanks PremiumAU:CYC vs AU:MX1Unlock the AU:MX1 top-analyst price target with TipRanks Premium
AU:EMVEMvision Medical Devices Ltd.AUD 1.45AUD 138.97M-16.37-18.99%Moderate BuyUnlock the AU:EMV analyst price target with TipRanks PremiumAU:CYC vs AU:EMVUnlock the AU:EMV top-analyst price target with TipRanks Premium
AU:OSLOncoSil Medical LtdAUD 0.63AUD 23.12M-1.31-47.19%―Unlock the AU:OSL analyst price target with TipRanks PremiumAU:CYC vs AU:OSLUnlock the AU:OSL top-analyst price target with TipRanks Premium
AU:IMRImricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 ShAUD 1.37AUD 521.84M-8.550.37%Moderate BuyUnlock the AU:IMR analyst price target with TipRanks PremiumAU:CYC vs AU:IMRUnlock the AU:IMR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:CYCCyclopharm Limited0.46-0.29-38.67%
AU:CMPCompumedics Limited0.24-0.11-32.39%
AU:MX1Micro-X Ltd.0.03-0.06-67.78%
AU:EMVEMvision Medical Devices Ltd.1.45-0.34-18.99%
AU:OSLOncoSil Medical Ltd0.63-0.51-44.88%
AU:IMRImricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh1.360.011.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts